GlassScriptPhysician profile
Harissa A Michael
NPI 1801288717
$4,316.21
in general payments reported to CMS, 2019-2025
23 companies · $590 in 2025
The $590 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $378 · 2021: $515 · 2022: $515 · 2023: $946 · 2024: $702 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,238.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $914.11 | 2022-2025 | Stellaris, Envista Mx60 Iol, Scoutpro Osmolarity System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $843.77 | 2019-2021 | |
| Abbvie INC. | $766.00 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $268.64 | 2019-2021 | |
| New World Medical,INC. | $264.61 | 2024-2025 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Lensar, INC. | $230.28 | 2024 | Lensar Laser System |
| Alcon Vision LLC | $213.64 | 2019-2025 | Clareon Panoptix Pro, Clareon, Rocklatan |
| Allergan, INC. | $128.03 | 2020-2022 | |
| Oyster Point Pharma, INC. | $127.75 | 2022-2024 | Tyrvaya |
| Eyevance Pharmaceuticals LLC | $94.43 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $71.40 | 2021-2024 | Acthar |
| Biotissue Holdings INC. | $66.81 | 2020-2025 | |
| Rayner Intraocular Lenses Limited | $46.29 | 2023-2024 | Rayone Spheric, Rayone Emv, Omidria |
| Rxsight INC | $41.38 | 2021-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $41.37 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $40.45 | 2019 | |
| Dompe US, INC. | $37.02 | 2021-2025 | Oxervate |
| Harrow Eye, LLC | $26.60 | 2024 | Iheezo |
| Johnson & Johnson Surgical Vision, INC. | $22.88 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $20.11 | 2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $17.24 | 2019 | |
| Thea Pharma INC. | $14.00 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harissa Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.